Walleye Capital
UTHR icon

Walleye Capital’s United Therapeutics UTHR Stock Holding History

Walleye Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28M Sell
2,166
-7,919
-79% -$3.94M 0.01% 1854
2025
Q4 		$4.91M Sell
10,085
-1,192
-11% -$555K 0.02% 1164
2025
Q3 		$4.73M Buy
+11,277
New +$3.79M 0.02% 952
2025
Q2 		– Sell
-649
Closed -$200K – 5072
2025
Q1 		$200K Buy
649
+323
+99% +$111K ﹤0.01% 3261
2024
Q4 		$115K Sell
326
-1,091
-77% -$401K ﹤0.01% 4069
2024
Q3 		$508K Sell
1,417
-7,675
-84% -$2.59M ﹤0.01% 3284
2024
Q2 		$2.9M Buy
9,092
+6,097
+204% +$1.61M 0.01% 1761
2024
Q1 		$688K Sell
2,995
-11,912
-80% -$2.69M ﹤0.01% 2932
2023
Q4 		$3.28M Buy
+14,907
New +$3.44M 0.01% 1403
2023
Q2 		– Sell
-18,574
Closed -$4.11M – 4902
2023
Q1 		$4.16M Buy
18,574
+14,441
+349% +$3.56M 0.06% 389
2022
Q4 		$1.15M Sell
4,133
-58,049
-93% -$14.7M 0.02% 909
2022
Q3 		$13M Buy
62,182
+47,122
+313% +$10.5M 0.25% 73
2022
Q2 		$3.55M Sell
15,060
-7,281
-33% -$1.48M 0.1% 231
2022
Q1 		$4.01M Buy
22,341
+20,332
+1,012% +$3.87M 0.11% 202
2021
Q4 		$434K Sell
2,009
-3,566
-64% -$700K 0.01% 1068
2021
Q3 		$1.03K Buy
+5,575
New +$1.1M 0.03% 423
2020
Q1 		– Sell
-490
Closed -$43K – 1696
2019
Q4 		$43K Buy
490
+380
+345% +$33.4K ﹤0.01% 1525
2019
Q3 		$9K Hold
110
– – ﹤0.01% 1778
2019
Q2 		$9K Sell
110
-688
-86% -$64.3K ﹤0.01% 1600
2019
Q1 		$94K Buy
+798
New +$93K 0.02% 1053

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Walleye Capital's UTHR Position: Q1 2026 in Review

Walleye Capital reduced its United Therapeutics (UTHR) stake by 79% in Q1 2026, selling an estimated $3.94M and leaving 2,166 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #1854.

Walleye Capital first reported a position in UTHR in Q1 2019 and has held it in 20 quarters since. The position peaked at $13M in Q3 2022. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Walleye Capital held 2,166 shares of United Therapeutics worth $1.28M as of Q1 2026.
  • Walleye Capital sold 7,919 United Therapeutics shares in Q1 2026, an estimated $3.94M.
  • United Therapeutics made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1854 holding.
  • Walleye Capital first reported a position in United Therapeutics in Q1 2019 and has held it in 20 quarters since.
  • Walleye Capital's United Therapeutics position peaked at $13M in Q3 2022.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.